Who Owns Kiniksa Pharmaceuticals International Stock?
NASDAQ: KNSAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 100.68%
- Institutions (% of float)
- 104.29%
- Held by insiders
- 3.46%
- Institutional holders
- 429
- Institutions 96.5%
- Insiders 3.5%
- Public and other 0.0%
Who owns Kiniksa Pharmaceuticals International stock?
Institutional investors own about 100.7% of Kiniksa Pharmaceuticals International's shares, spread across 429 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 3.46% of KNSA.
The largest institutional holders are FMR, LLC (18.58%), Blackrock Inc. (7.30%) and Baker Bros. Advisors, LP (7.03%). Together, the top 10 institutions control 61.4% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their KNSA positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of KNSA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 7.49M | 18.58% | +7.4% |
| Blackrock Inc. | 2.94M | 7.30% | +7.5% |
| Baker Bros. Advisors, LP | 2.83M | 7.03% | 0.0% |
| Rubric Capital Management LP | 2.81M | 6.98% | -29.7% |
| Tang Capital Management, LLC | 2.26M | 5.61% | 0.0% |
| Vanguard Portfolio Management LLC | 2.03M | 5.04% | +6.2% |
| Vanguard Capital Management LLC | 1.43M | 3.56% | +5.3% |
| Arrowstreet Capital, Limited Partnership | 1.09M | 2.71% | +14.3% |
| Morgan Stanley | 936.37K | 2.32% | -7.4% |
| State Street Corporation | 926.27K | 2.30% | +31.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of KNSA
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.32M | 3.27% |
| iShares Trust-iShares Russell 2000 ETF | 1.18M | 2.93% |
| Fidelity Select Portfolios-Select Health Care Portfolio | 1.04M | 2.58% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 954.72K | 2.37% |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 761.82K | 1.89% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 637.60K | 1.58% |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 581.26K | 1.44% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 551.98K | 1.37% |
| Fidelity Advisor Series VII-Fidelity Advisor Health Care Fund | 500.00K | 1.24% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 463.91K | 1.15% |
Frequently asked questions
Who is the largest shareholder of Kiniksa Pharmaceuticals International?
FMR, LLC is the largest institutional shareholder of KNSA, owning 18.58% of shares outstanding (7.49M shares) as of its latest 13F filing.
What percentage of Kiniksa Pharmaceuticals International is owned by institutions?
Institutions own about 100.7% of KNSA shares and 104.3% of the public float.
How much of Kiniksa Pharmaceuticals International do insiders own?
Insiders, such as officers and directors, own about 3.46% of KNSA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.